Author

Rui Li

Observed names: R Li, R. LI, R. Li, Rui-yuan Li

Institutions: Tongji University, Shanghai East Hospital

Observed institutions: Tongji University, Nanfang Hospital, First Affiliated Hospital of GuangXi Medical University, Shanghai East Hospital, Wuhan Union Hospital, Huazhong University of Science and Technology, Southern Medical University

ORCID: 0009-0004-9625-6488

Observed ORCID: 0009-0004-9625-6488

OpenAlex ID: A5002860993

EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop

2015 · C-F Yang, G-D Yang, et al. · Oncogene · 81

Analysis of altered proteins related to blast crisis in chronic myeloid leukemia by proteomic study

2011 · J. ZHANG, Z. JIN, et al. · International Journal of Laboratory Hematology · 16

Synergistic anticancer effect by targeting CDK2 and EGFR–ERK signaling

2023 · Jinhuan Wu, Yuping Chen, et al. · The Journal of Cell Biology · 13

Artificial Intelligence in Medical Metaverse: Applications, Challenges, and Future Prospects

2024 · Jia-ming Yang, Bao-jun Chen, et al. · Current Medical Science · 11

Construction of a Multimodal 3D Atlas for a Micrometer-Scale Brain–Computer Interface Based on Mixed Reality

2025 · Hong Zhou, Zi-neng Yan, et al. · Current Medical Science · 1

726P Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)

2022 · M. Zang, Q. Li, et al. · Annals of Oncology · 1

XPA lactylation is required for UV-induced DNA damage repair

2026 · Jie Yang, Xin Ding, et al. · Nucleic Acids Research

The Feasibility of Level Ib Sparing Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma Patients with High-Risk Factors: Based on International Guideline

2023 · Z. Meng, P. Li, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 8

Citation count: 123

H-index: 4

I10-index: 4